APPLICATION
ANDA064030
TYPE
ANDA
ORIGINAL APPROVAL
1996-07-18
LATEST ACTION
2017-03-10
ROUTE
OPHTHALMIC
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription
Products
ERYTHROMYCINPrescription
ERYTHROMYCIN 0.5% · OINTMENT · OPHTHALMIC
Approval history
2017-03-10Manufacturing (CMC) · Supplement 11 · unknownAP
2010-09-01Manufacturing (CMC) · Supplement 5AP
1996-07-18OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.